1. Home
  2. HAS vs QGEN Comparison

HAS vs QGEN Comparison

Compare HAS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$81.18

Market Cap

11.1B

ML Signal

HOLD

Logo Qiagen N.V.

QGEN

Qiagen N.V.

HOLD

Current Price

$47.05

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAS
QGEN
Founded
1923
1986
Country
United States
Netherlands
Employees
N/A
5700
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
10.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
HAS
QGEN
Price
$81.18
$47.05
Analyst Decision
Strong Buy
Buy
Analyst Count
11
7
Target Price
$88.55
$50.68
AVG Volume (30 Days)
1.6M
1.2M
Earning Date
10-23-2025
11-04-2025
Dividend Yield
3.45%
3.21%
EPS Growth
N/A
331.20
EPS
N/A
1.84
Revenue
$4,357,000,000.00
$2,070,781,000.00
Revenue This Year
$10.26
$7.12
Revenue Next Year
$6.23
$6.13
P/E Ratio
N/A
$25.56
Revenue Growth
0.79
5.32
52 Week Low
$49.00
$37.63
52 Week High
$83.45
$51.88

Technical Indicators

Market Signals
Indicator
HAS
QGEN
Relative Strength Index (RSI) 59.01 55.46
Support Level $81.24 $46.39
Resistance Level $83.38 $48.13
Average True Range (ATR) 1.77 0.67
MACD 0.19 0.18
Stochastic Oscillator 73.01 68.53

Price Performance

Historical Comparison
HAS
QGEN

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Share on Social Networks: